Does insulin suppress adipose tissue lipolysis by inhibiting hormone-sensitive lipase?

Insulin acts as the primary hormonal brake on the mobilization of energy stores, serving as a potent anti-lipolytic signal that prevents the breakdown of stored fat within adipose tissue. This regulation is critical for metabolic health, ensuring that the body shifts from utilizing stored fats to utilizing dietary glucose when insulin levels rise.

Mechanistic pathways

The suppression of lipolysis by insulin is driven by a precise intracellular signaling cascade that targets the enzymes responsible for fat breakdown:

• Enzymatic Inhibition: Insulin binds to its receptor on adipocytes, activating the Phosphoinositide 3-kinase (PI3K) and Akt pathway. This leads to the activation of phosphodiesterase 3B (PDE3B), which degrades cyclic AMP (cAMP).
• HSL Inactivation: The reduction in cAMP levels inhibits Protein Kinase A (PKA). Under fasting conditions, PKA activates hormone-sensitive lipase (HSL) by phosphorylating it at specific sites (Ser-563 and Ser-660). By reducing PKA activity, insulin ensures HSL remains in an inactive, dephosphorylated state.
• Reduced Fatty Acid Flux: By inhibiting HSL, the hydrolysis of triglycerides into diacylglycerols and eventually free fatty acids (FFAs) is halted. This results in a rapid and significant decrease in the release of FFAs and glycerol into the systemic circulation.

Clinical evidence

Research consistently validates insulin's high sensitivity in regulating fat tissue compared to its effects on glucose uptake:

• Adipose Sensitivity: Hyperinsulinemic-euglycemic clamp studies demonstrate that adipose tissue is exquisitely sensitive to insulin. Significant suppression of lipolysis occurs at very low physiological concentrations, with a half-maximal effective concentration (EC50) typically observed at 10–20 mU/m²/min.
• Gender Considerations: Evidence suggests that females, such as those in their mid-40s, often exhibit higher sensitivity to the anti-lipolytic effects of insulin than males. While systemic insulin resistance can occur, the anti-lipolytic action in subcutaneous fat is frequently preserved even when skeletal muscle glucose uptake begins to decline.

Bottom line

Insulin is a potent anti-lipolytic hormone that suppresses the release of free fatty acids by inhibiting hormone-sensitive lipase through a cAMP-dependent signaling pathway. This mechanism ensures efficient energy storage and prevents excessive lipid levels in the blood.